|
Medical News Experimental Microbicide Might Prevent Spread of HIV, Herpes, Pilot Study ShowsMarch 9, 2005 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! An experimental microbicide gel for women might help prevent the spread of HIV and the herpes simplex virus, according to pilot study data presented on Feb. 24 at the 12th Conference on Retroviruses and Opportunistic Infections in Boston, the New York Times reports (Bakalar, New York Times, 3/8). Microbicides include a range of products -- such as gels, films, sponges and other products -- that could help prevent the sexual transmission of HIV and other sexually transmitted diseases (Kaiser Daily HIV/AIDS Report, 3/3). Dr. Marla Keller and colleagues from Mount Sinai School of Medicine in New York City treated 10 HIV-positive women with the topical vaginal gel, called PRO 2000, which is manufactured by Indevus Pharmaceuticals, and applied a placebo gel to another 10 HIV-positive women. One hour later, the researchers collected and examined secretions from both groups for evidence of viral infection. The researchers found that PRO 2000 significantly reduced viral levels in HIV-positive women without causing an inflammatory response, according to the Times. A 14-day study to test whether repeated applications of the microbicide cause "unacceptable side effects" currently is under way, according to the Times. In addition, researchers are planning a larger study of the microbicide that will include 3,000 women at nine sites. Avoiding Pitfalls Back to other news for March 9, 2005
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved. A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. |
|